Skip to main content

Table 3 Somato-sensoric and autonomic neuropathy in the groups from baseline and follow-up

From: Long-term effects on the progress of neuropathy after diabetic Charcot foot: an 8.5-year prospective case–control study

  DM + CF (n = 11) DM − CF (n = 11) p value
Mod.NSS, baseline 2; 8 1; 6 0.946
Mod.NSS, follow-up 4; 7 3; 9
p value 0.250 0.557
  DM + CF (n = 11) DM − CF (n = 11) p value+
Healthy foot Charcot foot Right foot Left foot
Biothesiometry, baseline (V) 38 ± 15 40 ± 15 26 ± 11 24 ± 13 0.014*
Biothesiometry, follow-up (V) 38 ± 15 39 ± 15 40 ± 10 38 ± 10
Δfollow-up − 1 ± 11 − 1 ± 5 14 ± 13 14 ± 16 0.003*
  DM + CF (n = 11) DM − CF (n = 6) p value
Heart-rate variability, baseline (beats/min) 9.7 ± 5.9 14.3 ± 7.5 0.127
Heart-rate variability, follow-up (beats/min) 7.2 ± 4.0 12.6 ± 7.7
p value 0.053 0.762
Δfollow-up − 2.5 ± 3.7 − 0.4 ± 3.2 0.274
  1. Groups consists of diabetics with (DM + CF) or without (DM − CF) acute or chronic Charcot foot at baseline
  2. Data listed as (median; range) or (mean ± 1SD)
  3. * Significant at set level (α-level) of 0.05
  4. +Average of both feet in each group (DM + CF and DM − CF) compared